Cite
HARVARD Citation
Molina, J. et al. (2021). Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies. Antiviral therapy. 26 (6), pp. 95-105. [Online].